Pancreatic cancer, one of the deadliest cancers, is characterized by high rates of metastasis
and intense desmoplasia, both of which are associated with changes in fibrillar type I …

Simple Summary PDAC is one of the most malignant tumors and its treatment, whether
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …

Tumor-associated macrophages (TAMs) are increasingly considered a viable target for
tumor imaging and therapy. Previously, we reported that innovative surface-functionalization …

MUC1, a type I transmembrane protein, is significantly overexpressed and aberrantly
glycosylated in tumors of epithelial origin. By virtue of its aberrant signaling due to loss of …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor
prognosis. The lack of early diagnosis and the absence of suitable biomarkers coupled with …

Purpose Tumor volume largely determines the success of local control of borderline
resectable and locally advanced pancreatic cancer with current therapy. We hypothesized …

Simple Summary In their advanced stages, the mainstay of kidney cancer treatment is with
medications such as targeted or immune therapies. Breakthroughs in scientific …

Pancreatic ductal adenocarcinomas are highly malignant cancers characterized by
extensive invasion into surrounding tissues, metastasis to distant organs, and a limited …

Purpose 1) To assess the usefulness of an elastic belt bracing the upper abdomen for
reducing the miscalculated areas of the pancreas on 3.0 T magnetic resonance …

Pancreatic cancer is an aggressive disease with poor prognosis. Only about 15–20% of
patients diagnosed with pancreatic cancer can undergo surgical resection, while the …